Holen Sie sich die Stockscreener-App
74.03
0.05%
0.035
Schlusskurs vom Vortag:
$73.99
Offen:
$74.05
24-Stunden-Volumen:
1.46M
Relative Volume:
0.59
Marktkapitalisierung:
$16.46B
Einnahmen:
$4.04B
Nettoeinkommen (Verlust:
$557.10M
KGV:
30.71
EPS:
2.4102
Netto-Cashflow:
$916.70M
1W Leistung:
+3.00%
1M Leistung:
+10.14%
6M Leistung:
+27.59%
1J Leistung:
-8.42%
1-Tages-Spanne:
$73.99
$74.18
1-Wochen-Bereich:
$73.86
$74.71
52-Wochen-Spanne:
$51.90
$84.39
Hologic Inc Stock (HOLX) Company Profile
Firmenname
Hologic Inc
Sektor
Telefon
(508) 263-2900
Adresse
250 CAMPUS DRIVE, MARLBOROUGH, MA
Vergleichen Sie HOLX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.02 | 16.47B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
548.78 | 193.74B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
186.17 | 53.26B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
260.81 | 37.87B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
76.09 | 37.61B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
290.07 | 21.40B | 2.96B | 487.70M | 344.00M | 6.6758 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Hochstufung | Argus | Hold → Buy |
| 2025-08-06 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-05-27 | Bestätigt | Needham | Hold |
| 2025-03-03 | Herabstufung | Argus | Buy → Hold |
| 2025-02-06 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Herabstufung | Needham | Buy → Hold |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-12-10 | Bestätigt | Needham | Buy |
| 2024-10-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-06-27 | Eingeleitet | Stephens | Overweight |
| 2024-04-03 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-14 | Hochstufung | Needham | Hold → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-07-20 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-07-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-10-14 | Eingeleitet | Redburn | Neutral |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Herabstufung | Needham | Buy → Hold |
| 2020-11-05 | Bestätigt | Needham | Buy |
| 2020-06-30 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-06-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Bestätigt | Needham | Buy |
| 2020-04-30 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Bestätigt | Needham | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Bestätigt | Needham | Buy |
| 2019-05-02 | Bestätigt | Needham | Buy |
| 2019-01-31 | Bestätigt | Needham | Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Eingeleitet | UBS | Neutral |
| 2018-09-13 | Herabstufung | BofA/Merrill | Buy → Neutral |
Alle ansehen
Hologic Inc Aktie (HOLX) Neueste Nachrichten
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Statistical indicators supporting Hologic Inc.’s strengthPortfolio Risk Summary & Growth Focused Entry Point Reports - newser.com
Best data tools to analyze Hologic Inc. stockWeekly Investment Summary & Low Risk High Reward Trade Ideas - newser.com
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now? - Yahoo
Hologic Inc. recovery potential after sell offWeekly Gains Summary & Smart Money Movement Alerts - newser.com
Real time breakdown of Hologic Inc. stock performanceWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com
Will Hologic Inc. stock attract ESG investorsInflation Watch & AI Forecasted Stock Moves - newser.com
Hologic Inc. stock momentum explainedMarket Weekly Review & AI Driven Price Predictions - newser.com
How Hologic Inc. (HO1) stock responds to bond marketWeekly Loss Report & Verified Momentum Watchlists - newser.com
Is Hologic Inc. (HO1) stock bottoming after sell offQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Women’s health could benefit from the private equity treatment - Financial Times
Key deals this week: United States Antimony, Grindr, Eli Lilly, Hologic and more - Seeking Alpha
Finanzdaten der Hologic Inc-Aktie (HOLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.61%
0.78%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):